In summary, Fb-secreted IL-6, further potentiated by radiotherapy, activates the IL-6/IL-6R/ERK pathway, which in turn induces and maintains radioresistance and the EMT status in HNSCC cells. This evidence concerns the gene IL6 and head and neck squamous cell carcinoma.